Does LEMZOPARLIMAB Cause Febrile neutropenia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Febrile neutropenia have been filed in association with LEMZOPARLIMAB. This represents 21.7% of all adverse event reports for LEMZOPARLIMAB.
5
Reports of Febrile neutropenia with LEMZOPARLIMAB
21.7%
of all LEMZOPARLIMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Febrile neutropenia From LEMZOPARLIMAB?
Of the 5 reports, 4 (80.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEMZOPARLIMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LEMZOPARLIMAB Cause?
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)